Immunological remission in PLA2R-antibody-associated membranous nephropathy: cyclophosphamide versus rituximab

Kidney Int. 2018 Apr;93(4):1016-1017. doi: 10.1016/j.kint.2017.12.019.

¹ Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Nephrology, Nijmegen, The Netherlands. Electronic address: [email protected].
² AP-HP, Hôpital Tenon, Department of Nephrology and Dialysis, F-75020, Paris, France.
³ Unité de Recherche Clinique de l'Est Parisien (URC-Est) Hôpitaux Universitaires Paris Est (AP-HP) Hôpital Saint-Antoine, F-75012, Paris, France.
⁴ Laboratory of Medical Immunology, Radboud University Medical Center, Nijmegen, The Netherlands.
⁵ Sorbonne Universités, UPMC Univ Paris 06, F-75005, Paris, France; INSERM, UMR_S 1155, F-75020, Paris, France.
⁶ AP-HP, Hôpital Tenon, Department of Nephrology and Dialysis, F-75020, Paris, France; Sorbonne Universités, UPMC Univ Paris 06, F-75005, Paris, France; INSERM, UMR_S 1155, F-75020, Paris, France.
⁷ Radboud University Medical Center, Radboud Institute for Health Sciences, Department of Nephrology, Nijmegen, The Netherlands.

No abstract available

Publication types